Standout Papers

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-posit... 2012 2026 2016 2021 505
  1. Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study (2012)
    Thomas Bachelot, Gilles Romieu et al. The Lancet Oncology

Immediate Impact

3 by Nobel laureates 6 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2024 Standout
13 intermediate papers

Works of Marta Jimenez being referenced

Genomic and Immune Characterization of Metastatic Breast Cancer (Mbc): and Ancillary Study of the Safir01 & Moscato Trials
2014
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
2012 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Marta Jimenez 867 928 404 51 1.3k
Mikhail Shtivelband 726 699 315 35 1.2k
Yuan Liu 1141 1308 746 41 1.7k
Conleth G. Murphy 978 417 210 54 1.4k
José Pablo Leone 693 538 354 84 1.3k
S-A. Im 776 435 233 82 1.1k
Lesli A. Kiedrowski 564 612 691 47 1.3k
Cecilia Bozzetti 818 748 326 52 1.4k
H. Léna 935 959 174 64 1.4k
Stephen P. Anthony 866 360 593 52 1.5k
Saeed Sadeghi 1095 498 434 40 1.6k

All Works

Loading papers...

Rankless by CCL
2026